Health Care·Life Sciences Tools & Services·$174.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.62 | N/A | -0.10% |
management commentary, guidance changes, and full analysis available with Pro.
| -0.10% |
Tone: Defensive
Management acknowledged the tough market environment and emphasized their commitment to innovation. They did not provide specific guidance for future quarters.
Management expressed concerns about market conditions impacting performance.
They highlighted ongoing investments in innovation despite the current challenges.
Thermo Fisher's earnings report indicates a slight miss on EPS, which contributed to a 1.24% decline in stock price. The lack of revenue data and guidance may raise concerns among investors about the company's near-term outlook. Management's cautious tone suggests they are navigating a challenging market environment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
KONINKLIJKE PHILIPS ADR
Oct 22, 2018